tiprankstipranks
PainReform (PRFX)
NASDAQ:PRFX
US Market
Holding PRFX?
Track your performance easily

PainReform (PRFX) Technical Analysis

151 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
PainReform’s (PRFX) Moving Averages Convergence Divergence (MACD) indicator is 0.19, suggesting PainReform is a Sell.
PainReform’s (PRFX) 20-Day exponential moving average is 2.81, while PainReform’s (PRFX) share price is $2.97, making it a Buy.
PainReform’s (PRFX) 50-Day exponential moving average is 3.46, while PainReform’s (PRFX) share price is $2.97, making it a Sell.

PainReform (PRFX) Pivot Points

Nov 23, 2024, 06:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.11
3.50
3.83
4.21
4.55
4.93
5.26
Fibonacci
3.50
3.77
3.94
4.21
4.49
4.66
4.93
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PainReform (PRFX) Moving Averages

Nov 23, 2024, 06:28 AM
Period
Simple
Exponential
MA5
3.44Sell
3.46Sell
MA10
2.85Buy
3.09Buy
MA20
2.51Buy
2.81Buy
MA50
2.65Buy
3.46Sell
MA100
5.53Sell
7.34Sell
MA200
17.75Sell
20.23Sell
PainReform’s (PRFX) 10-Day exponential moving average is 3.09, while PainReform’s (PRFX) share price is $2.97, making it a Buy.
PainReform’s (PRFX) 100-Day exponential moving average is 7.34, while PainReform’s (PRFX) share price is $2.97, making it a Sell.
PainReform’s (PRFX) stock price is $2.97 and PainReform’s (PRFX) 50-day simple moving average is 2.65, creating a Buy signal.
PainReform’s (PRFX) stock price is $2.97 and PainReform’s (PRFX) 100-day simple moving average is 5.53, creating a Sell signal.
PainReform’s (PRFX) stock price is $2.97 and PainReform’s (PRFX) 200-day simple moving average is 17.75, creating a Sell signal.

PainReform (PRFX) Technical Indicators

Nov 23, 2024, 06:28 AM
Name
Value
Implied Action
RSI (14)
53.05
Neutral
STOCH (9,6)
43.70
Neutral
STOCHRSI (14)
46.55
Neutral
MACD (12,26)
0.19
Sell
ADX (14)
20.86
Neutral
Williams %R
-73.91
Buy
CCI (14)
99.55
Neutral
ATR (14)
0.76
-
Ultimate Oscillator
49.95
Neutral
ROC
77.78
Buy
PainReform’s (PRFX) Relative Strength Index (RSI) is 53.05, creating a Neutral signal.
PainReform’s (PRFX) Trend Strength Indicator (ADX) is 20.86, creating a Neutral signal.
PainReform’s (PRFX) Commodity Channel Index (CCI) is 99.55, creating a Neutral signal.
PainReform’s (PRFX) Price Rate of Change (ROC) is 77.78, creating a Buy signal.

FAQ

Is PRFX a Buy, Hold, or Sell?
Based on PRFX’s technical indicators, PRFX is a Hold.
    What is PRFX’s RSI (14)?
    PRFX’s RSI (14) is 53.05, which suggests PRFX is a Neutral.
      What is PRFX’s MACD?
      PRFX’s MACD is 0.19, which suggests PRFX is a Sell.
        What is PRFX’s 5-day moving average?
        PRFX’s 5-day moving average is 3.44, which suggests PRFX is a Sell.
          What is PRFX’s 20-day moving average?
          PRFX 20-day moving average is 2.51, which suggests PRFX is a Buy.
            What is PRFX’s 50-day moving average?
            PRFX’s 50-day moving average is 2.65, which suggests PRFX is a Buy.
              What is PRFX’s 200-day moving average?
              PRFX’s 200-day moving average is 17.75, which suggests PRFX is a Sell.
                What is PRFX’s Williams % R (14)?
                PRFX’s Williams % R (14) is -73.91, which suggests PRFX is a Buy.
                  What is PRFX’s CCI (14)?
                  PRFX’s CCI (14) is 99.55, which suggests PRFX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis